Concepedia
Statistics
Publications
8
Citations
272
H-Index
Active since
2011
Affiliations
University of Plymouth(Current)
Peninsula College of Medicine and Dentistry
University of Cambridge
University College London
MRC Clinical Trials Unit at UCL
Marie‐Louise Zeissler is an author at University of Plymouth specializing in neurodegenerative diseases, medicine, and cell biology.
Top concepts
MedicineCell BiologyNeurodegenerative DiseasesHealthPathologyBiomarkersImmunologyProteomicsAutoimmunityImmune System
Publications per year
2011–2024
Δ<sup>9</sup>‐tetrahydrocannabinol (Δ<sup>9</sup>‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease
Camille Carroll, Marie‐Louise Zeissler, C. Oliver Hanemann et al. · Neuropathology and Applied Neurobiology · 2012 · 102 citations · Full text
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis
Marie‐Louise Zeissler, Jordan Eastwood, Kieran McCorry et al. · Oncotarget · 2016 · 53 citations · Full text
Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson’s disease
Camille Carroll, Marie‐Louise Zeissler, Neil Chadborn et al. · Neurochemistry International · 2011 · 32 citations · Full text
Transcriptional Regulation, Neurodegenerative Diseases, Iron Metabolism +9
Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease
Sonia Gandhi, Cristina Gonzalez‐Robles, Marie‐Louise Zeissler et al. · Brain · 2023 · 28 citations · Full text
Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative
Cristina Gonzalez‐Robles, Rimona S. Weil, Daniel J. van Wamelen et al. · Journal of Parkinson s Disease · 2023 · 19 citations · Full text
1–5 of 8